Quick Answer
Pacira BioSciences, Inc. reported Operating Income of $19.19 million for fiscal year 2025.
Pacira BioSciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $19.19M | +126.2% |
| 2024 | -$73.37M | -183.7% |
| 2023 | $87.67M | +46.1% |
| 2022 | $60.02M | -33.3% |
| 2021 | $89.92M | +94.0% |
| 2020 | $46.35M | +342.3% |
| 2019 | $10.48M | -34.2% |
| 2018 | $15.91M | +163.8% |
| 2017 | -$24.94M | +22.1% |
| 2016 | -$32.02M | -438.7% |
| 2015 | $9.46M | +283.1% |
| 2014 | -$5.17M | +90.3% |
| 2013 | -$53.29M | -8.1% |
| 2012 | -$49.30M | -26.1% |
| 2011 | -$39.10M | -72.2% |
| 2010 | -$22.71M | +20.5% |
| 2009 | -$28.55M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.36M | +104.6% | -25.1% |
| June 30, 2025 | $8.50M | -69.9% | +327.1% |
| March 31, 2025 | $1.99M | -84.9% | +101.4% |
| September 30, 2024 | -$139.53M | -887.4% | -594.1% |
| June 30, 2024 | $28.24M | -29.2% | +113.7% |
| March 31, 2024 | $13.21M | +527.4% | -25.4% |
| September 30, 2023 | $17.72M | -16.8% | -55.6% |
| June 30, 2023 | $39.88M | +27.7% | +1390.1% |
- Pacira BioSciences, Inc. showed an increase of +126.2% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, Pacira BioSciences, Inc.’s operating income has grown by 167.2% (from -$28.55 million to $19.19 million).
- The most recent figure is from Pacira BioSciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: